204 related articles for article (PubMed ID: 12767466)
1. Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questions.
Lewis W
Antiviral Res; 2003 May; 58(3):189-97. PubMed ID: 12767466
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial DNA replication, nucleoside reverse-transcriptase inhibitors, and AIDS cardiomyopathy.
Lewis W
Prog Cardiovasc Dis; 2003; 45(4):305-18. PubMed ID: 12638094
[TBL] [Abstract][Full Text] [Related]
3. A brief overview of mechanisms of mitochondrial toxicity from NRTIs.
Kohler JJ; Lewis W
Environ Mol Mutagen; 2007; 48(3-4):166-72. PubMed ID: 16758472
[TBL] [Abstract][Full Text] [Related]
4. Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA.
Koczor CA; Lewis W
Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1493-504. PubMed ID: 20929279
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial defects arise from nucleoside/nucleotide reverse transcriptase inhibitors in neurons: Potential contribution to HIV-associated neurocognitive disorders.
Hung KM; Chen PC; Hsieh HC; Calkins MJ
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):406-413. PubMed ID: 27840304
[TBL] [Abstract][Full Text] [Related]
6. Nucleoside reverse transcriptase inhibitors induced hepatocellular mitochondrial DNA lesions and compensatory enhancement of mitochondrial function and DNA repair.
Liang Q; Zeng J; Wu J; Qiao L; Chen Q; Chen D; Zhang Y
Int J Antimicrob Agents; 2018 Mar; 51(3):385-392. PubMed ID: 28843815
[TBL] [Abstract][Full Text] [Related]
7. Possible ways nucleoside analogues can affect mitochondrial DNA content and gene expression during HIV therapy.
Côté HC
Antivir Ther; 2005; 10 Suppl 2():M3-11. PubMed ID: 16152702
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial toxicity and HIV therapy.
White AJ
Sex Transm Infect; 2001 Jun; 77(3):158-73. PubMed ID: 11402222
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress in NRTI-induced toxicity: evidence from clinical experience and experiments in vitro and in vivo.
Day BJ; Lewis W
Cardiovasc Toxicol; 2004; 4(3):207-16. PubMed ID: 15470269
[TBL] [Abstract][Full Text] [Related]
10. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC
Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687
[TBL] [Abstract][Full Text] [Related]
11. HIV and mitochondrial toxicity in children.
Foster C; Lyall H
J Antimicrob Chemother; 2008 Jan; 61(1):8-12. PubMed ID: 17999978
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis.
Lewis W; Kohler JJ; Hosseini SH; Haase CP; Copeland WC; Bienstock RJ; Ludaway T; McNaught J; Russ R; Stuart T; Santoianni R
AIDS; 2006 Mar; 20(5):675-84. PubMed ID: 16514297
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of HIV and nucleoside reverse transcriptase inhibitor injury to mitochondria.
Moyle G
Antivir Ther; 2005; 10 Suppl 2():M47-52. PubMed ID: 16152705
[TBL] [Abstract][Full Text] [Related]
14. Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy.
Lewis W
Antivir Ther; 2005; 10 Suppl 2():M13-27. PubMed ID: 16152703
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.
Brinkman K; Smeitink JA; Romijn JA; Reiss P
Lancet; 1999 Sep; 354(9184):1112-5. PubMed ID: 10509516
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reverse-transcriptase inhibitors.
Martin AM; Hammond E; Nolan D; Pace C; Den Boer M; Taylor L; Moore H; Martinez OP; Christiansen FT; Mallal S
Am J Hum Genet; 2003 Mar; 72(3):549-60. PubMed ID: 12587093
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial DNA mutations in ageing and disease: implications for HIV?
Payne BA; Gardner K; Chinnery PF
Antivir Ther; 2015; 20(2):109-20. PubMed ID: 25032944
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis identifies prohibitin down-regulation as a crucial event in the mitochondrial damage observed in HIV-infected patients.
Ciccosanti F; Corazzari M; Soldani F; Matarrese P; Pagliarini V; Iadevaia V; Tinari A; Zaccarelli M; Perfettini JL; Malorni W; Kroemer G; Antinori A; Fimia GM; Piacentini M
Antivir Ther; 2010; 15(3):377-90. PubMed ID: 20516557
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.
Buffet M; Schwarzinger M; Amellal B; Gourlain K; Bui P; Prévot M; Deleuze J; Morini JP; Gorin I; Calvez V; Dupin N
J Clin Virol; 2005 May; 33(1):60-4. PubMed ID: 15797366
[TBL] [Abstract][Full Text] [Related]
20. Evidence of nucleoside analogue reverse transcriptase inhibitor--associated genetic and structural defects of mitochondria in adipose tissue of HIV-infected patients.
Walker UA; Bickel M; Lütke Volksbeck SI; Ketelsen UP; Schöfer H; Setzer B; Venhoff N; Rickerts V; Staszewski S
J Acquir Immune Defic Syndr; 2002 Feb; 29(2):117-21. PubMed ID: 11832679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
